Procept Biorobotics Corp (PRCT) Peer Comparison

$20.83

$0.23 (1.12%)

As on 28-Aug-2026 16:00EDT

Market cap

$1,186 Mln

Revenue (TTM)

$337 Mln

P/E Ratio

--

P/B Ratio

3.5

Div. Yield

0 %

Edit

	Procept Biorobotics Corp (PRCT)	10X Genomics Inc (TXG)	Avantor (AVTR)	Bio-Rad Laboratories	Bruker (BRKR)	Glaukos Corp (GKOS)	Lantheus Holdings (LNTH)	Merit Medical Systems (MMSI)	Penumbra (PEN)	Repligen (RGEN)
Market cap ($ Mln)	1,186	8,018	9,638	9,762	8,697	10,906	6,578	5,403	12,753	9,948
Revenue ($ Mln)	337	617	6,561	2,589	3,500	613	1,556	1,579	1,505	785
Net Profit ($ Mln)	-109.76	-75.13	-578.00	222.40	-71.20	-188.05	275.31	145.56	160.59	41.54
Net Margin (%)	-32.54	-12.18	-8.81	8.59	-2.03	-30.68	17.69	9.22	10.67	5.29
RoE (%)	-31.09	-9.26	-10.33	3.04	-3.21	-28.10	22.93	8.92	10.86	1.97
Price to Earnings	--	--	--	44.47	--	--	24.11	37.24	79.35	251.81
Price-To-Book	3.47	10.23	1.68	1.26	3.79	16.38	5.00	3.18	8.41	4.86

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Operating Revenue	337.34	1,504.87	612.84	785.10	2,589.30
Cost of Revenue	122.31	483.98	127.96	384.30	1,245.50
Gross Profit	196.23	942.44	393.22	347.62	1,343.60
Operating Expenses	329.26	833.56	565.37	335.50	1,108.90
Operating Profit (EBIT)	-114.23	187.34	-80.49	65.30	235.00
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-109.47	203.83	-192.83	52.15	350.40
Provision for Tax	0.24	43.24	-4.79	10.61	128.00
Profit after Tax (Net Income)	-109.76	160.59	-188.05	41.54	222.40
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	93.19	0.00	0.00	0.00

Liabilities ($ Mln)

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Shareholder's Funds	340.07	1,530.77	682.49	2,112.03	7,173.90
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	75.09	210.18	135.71	705.49	2,116.80
Current Liabilities	64.20	233.78	102.33	132.66	961.30
Total Liabilities	508.08	1,826.52	893.49	2,949.70	10,576.50

Assets ($ Mln)

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Non-Current Assets	59.07	630.60	404.74	1,749.63	7,231.50
Current Assets	420.29	1,344.12	515.78	1,200.55	3,020.50
Total Assets	508.08	1,826.52	893.49	2,949.70	10,576.50
Total Debt*	77.50	212.71	102.84	690.94	1,203.70
Net Current Assets	356.09	1,110.35	413.45	1,067.90	2,059.20

Cashflow ($ Mln)

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Cash From Operating Activities	-48.99	238.66	-46.34	117.42	532.20
Cash Flow from Investing Activities	-9.36	-404.59	-77.61	-298.47	-189.70
Cash from Financing Activities	11.19	26.53	11.89	-15.21	-283.20
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
ROCE (%)	-20.62	11.76	-22.53	1.79	8.98
ROE (%)	-31.09	10.86	-28.10	1.97	3.04
ROA (%)	-19.85	7.95	-18.00	1.36	2.02
EBIT Margin (%)	-31.42	13.63	-30.58	9.87	-5.99
Net Margin (%)	-32.54	10.67	-30.68	5.29	8.59
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Revenue Growth (%)	22.69	17.55	41.55	16.49	1.37
EBIT Growth (%)	-32.06	17.49	-116.42	920.91	-131.06
Net Profit Growth (%)	-30.44	8.72	-102.66	400.42	-30.32
EPS Growth (%)	-25.34	8.12	-96.88	394.30	-29.66
Book Value Growth (%)	-13.52	17.33	-12.65	2.16	2.19

Valuation Ratios

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Price / Earnings	-18.46	68.93	-34.59	189.42	--
Price / Book Value	3.47	8.58	9.90	4.86	--
Dividend Yield (%)	0.00	--	--	0.00	--
EV/EBITDA	-9.88	53.25	-43.50	81.02	--
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Debt to Equity	0.15	0.00	0.00	0.26	0.11
Short term debt to equity ratio	0.01	0.01	0.00	0.01	0.06
Current Ratio	6.55	5.75	5.04	9.05	3.14
Quick Ratio	5.35	3.86	4.46	7.64	2.33
Interest Coverage	-30.52	157.91	-38.31	3.36	8.18

Operating Efficiency Ratios

	Procept Biorobotics Corp (PRCT)	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Debtors to sales (%)	31.90	12.65	22.67	20.09	17.06
Asset Turnover	0.61	0.74	0.59	0.26	0.24
Receivable days	99.02	46.54	60.95	72.41	65.39
Inventory Days	207.18	331.92	193.84	146.53	221.09
Payable days	44.61	26.16	60.19	29.05	37.02
Cash Conversion Cycle	261.59	352.30	194.60	189.88	249.46

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly